Anand Ananthakrishnan
As the Senior Director of Drug Safety and Pharmacovigilance at Blueprint Medicines, I lead a high-performance team of... | Lexington, Massachusetts, United States
*50 free lookup(s) per month.
No credit card required.
Anand Ananthakrishnan’s Emails aa****@bl****.com
Anand Ananthakrishnan’s Phone Numbers No phone number available.
Social Media
Anand Ananthakrishnan’s Location Lexington, Massachusetts, United States
Anand Ananthakrishnan’s Expertise As the Senior Director of Drug Safety and Pharmacovigilance at Blueprint Medicines, I lead a high-performance team of safety professionals who ensure the safety and efficacy of our innovative therapies for patients with rare diseases. I have over 20 years of experience in the field of drug safety and pharmacovigilance, (specifically PV IT infrastructure) with certifications in software quality and testing. I am a strategic and creative thinker who can solve complex problems and drive continuous improvement in safety systems and processes. I am also a thought leader who can influence and collaborate with internal and external stakeholders, such as regulatory agencies, clinical teams, and vendors. My mission is to deliver excellence in drug safety and pharmacovigilance and to contribute to the advancement of science and medicine.
Anand Ananthakrishnan’s Current Industry Blueprint Medicines
Anand
Ananthakrishnan’s Prior Industry
Aris Global
|
Imclone Systems A Wholly Owned Subsidiary Of Eli Lilly
|
Celgene
|
Vertex Pharmaceuticals
|
Fresenius Medical Care North America
|
Blueprint Medicines
Not the Anand Ananthakrishnan you were looking for?
Find accurate emails & phone numbers for over 700M professionals.
Work Experience
Blueprint Medicines
Senior Director, Drug Safety and Pharmacovigilance
Tue Jun 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time) — Present
Blueprint Medicines
Director, Drug Safety and Pharmacovigilance
Fri Jun 01 2018 00:00:00 GMT+0000 (Coordinated Universal Time) — Sat May 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Fresenius Medical Care North America
Director, PV Safety Systems and Operations
Mon Aug 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) — Sun Jul 01 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Vertex Pharmaceuticals
Associate Director, Safety Systems
Tue Nov 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) — Mon Aug 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Celgene
Senior consultant
Sun May 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) — Tue Nov 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Imclone Systems A Wholly Owned Subsidiary Of Eli Lilly
Senior Manager, Development Informatics
Mon Jun 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) — Sun May 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Aris Global
Various Positions
Tue May 01 2001 00:00:00 GMT+0000 (Coordinated Universal Time) — Mon Jun 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time)Skills
Languages
Anand Ananthakrishnan Email Addresses
FAQ About Anand Ananthakrishnan
-
Anand Ananthakrishnan is located at
Lexington, Massachusetts, United States -
Anand Ananthakrishnan is a
As the Senior Director of Drug Safety and Pharmacovigilance at Blueprint Medicines, I lead a high-performance team of safety professionals who ensure the safety and efficacy of our innovative therapies for patients with rare diseases. I have over 20 years of experience in the field of drug safety and pharmacovigilance, (specifically PV IT infrastructure) with certifications in software quality and testing. I am a strategic and creative thinker who can solve complex problems and drive continuous improvement in safety systems and processes. I am also a thought leader who can influence and collaborate with internal and external stakeholders, such as regulatory agencies, clinical teams, and vendors. My mission is to deliver excellence in drug safety and pharmacovigilance and to contribute to the advancement of science and medicine. Blueprint Medicines -
Anand Ananthakrishnan currently works in the
Blueprint Medicines -
Anand Ananthakrishnan specializes in
As the Senior Director of Drug Safety and Pharmacovigilance at Blueprint Medicines, I lead a high-performance team of safety professionals who ensure the safety and efficacy of our innovative therapies for patients with rare diseases. I have over 20 years of experience in the field of drug safety and pharmacovigilance, (specifically PV IT infrastructure) with certifications in software quality and testing. I am a strategic and creative thinker who can solve complex problems and drive continuous improvement in safety systems and processes. I am also a thought leader who can influence and collaborate with internal and external stakeholders, such as regulatory agencies, clinical teams, and vendors. My mission is to deliver excellence in drug safety and pharmacovigilance and to contribute to the advancement of science and medicine. -
Anand Ananthakrishnan speaks the following languages:
No languages available. -
Anand Ananthakrishnan has prior experience in the following industries:
Blueprint Medicines , Fresenius Medical Care North America , Vertex Pharmaceuticals , Celgene , Imclone Systems A Wholly Owned Subsidiary Of Eli Lilly , Aris Global -
Anand Ananthakrishnan has the following professional experience:
Blueprint Medicines , Blueprint Medicines , Fresenius Medical Care North America , Vertex Pharmaceuticals , Celgene , Imclone Systems A Wholly Owned Subsidiary Of Eli Lilly , Aris Global . -
You can view Anand Ananthakrishnan’s
LinkedIn profile at LinkedIn URL. -
Anand Ananthakrishnan’s work email addresses are
[email protected] . -
Anand Ananthakrishnan works at
Blueprint Medicines
People you may be interested in
- Jonathan Snow
- Win Naing
- Roxana Hijaouy
- Wen Qi Phang
- Anesia Lynch
- Caleb Glueck
CRNA at Good Shepherd at Good Shepherd Health Care System
Facility Engineer at JLL
Design Engineering Manager at North American Lighting
Pricing Actuary at AIA Australia | FIAA
LPN
Social Studies/English Teacher